CN102119971A - Traditional Chinese medicine for treating coronary heart disease - Google Patents
Traditional Chinese medicine for treating coronary heart disease Download PDFInfo
- Publication number
- CN102119971A CN102119971A CN2011100482513A CN201110048251A CN102119971A CN 102119971 A CN102119971 A CN 102119971A CN 2011100482513 A CN2011100482513 A CN 2011100482513A CN 201110048251 A CN201110048251 A CN 201110048251A CN 102119971 A CN102119971 A CN 102119971A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart disease
- chinese medicine
- coronary heart
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to a traditional Chinese medicine for treating coronary heart disease, which is prepared from the following raw material medicines in part by weight: 1 to 3 parts of peach twig, 1 to 3 parts of potentilla discolor bunge, 0.5 to 1 part of musk, 2 to 5 parts of collina, 1 to 3 parts of plantain herb and 0.5 to 1 part of star aniseed. The raw materials of the traditional Chinese medicine are combined rationally and supplemented with one another, can be used for fundamentally treating the coronary heat disease and has a good treatment effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of coronary heart disease.
Background technology
Coronary heart disease is a kind of modal heart disease, be meant the myocardial dysfunction that causes because of coronary stricture, blood supply insufficiency and (or) organic disease, so claim ischemic heart desease (IHD) again, a kind of pain of squeezing property takes place in symptom performance thoracic cavity central authorities, and can delay to neck, chin, arm, back and stomach, other of outbreak may symptoms have dizzy, tachypnea, perspire, shiver, feel sick and faint, and severe patient may be because heart failure and death.The traditional Chinese medical science is thought: " heart master blood, the lung main force " is to say that H﹠L is two adjacent in thoracic cavity organs, heart pro-lung after, heart is responsible for advancing the motion of blood, the lung master breathes.This has just caused the research of medical circle to breathing and heart relation, and the cardiopulmonary relation is complicated staggered, and the oxygen of heart consumption all derives from lung, and lung goes wrong and directly causes heart disease.The traditional Chinese medical science think " cardiopulmonary homology " this be the theoretical source that cardiopulmonary are ruled together, the oxygen consumption of heart own accounts for about 20% of whole human body, if pathological changes appears in pulmonary, anoxybiotic at first is exactly heart.If the long time mild anoxia can make myocardial contraction strengthen, heart rate is accelerated to cause coronary heart disease, and blood pressure, heart rate all descend during severe depletion of oxygen, cause myocardial necrosis, mental and physical efforts master's depletion, even sudden cardiac arrest.
Summary of the invention
The object of the present invention is to provide the Chinese medicine of the good treatment coronary heart disease of a kind of therapeutic effect.
The present invention is by the following technical solutions:
A kind of Chinese medicine for the treatment of coronary heart disease, make by the crude drug of following parts by weight:
Ramulus Persicae 1-3 part, Herba Potentillae Discoloris 1-3 part, Moschus 0.5-1 part, Pemisetum flaccidum Griseb. 2-5 part, Herba Plantaginis 1-3 part and anistree 0.5-1 part.
Preferably make: 2 parts of Ramulus Persicae, 2 parts of Herba Potentillae Discoloris, 0.5 part in Moschus, 3 parts of Pemisetum flaccidum Griseb., 2.3 parts of Herba Plantaginiss and anistree 0.5 part by the crude drug of following parts by weight.
The present invention mixes each raw material, is ground into fine powder, directly take, and four times a day, a 2-3 gram is used warm water delivery service.
The peach branch that used Ramulus Persicae is gathered for the lunar calendar first month of the lunar year among the present invention, Herba Potentillae Discoloris is that lunar calendar the fifth day of a lunar month in May is gathered, Herba Plantaginis is that lunar calendar the fifth day of a lunar month in May is gathered.
Among the present invention, Ramulus Persicae, bitter in the mouth is controlled cardiac and abdominal pain; Herba Potentillae Discoloris, sweet in the mouth, little hardship, property is flat, and is nontoxic, heat-clearing and toxic substances removing, cooling blood for hemostasis; Moschus, acrid in the mouth, warm in nature, GUIXIN, spleen channel, inducing resuscitation, promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain is used for the calentura coma, apoplexy syncope due to accumulation of phlegm, stagnation of QI sudden syncope, attacked by pestiferous factors stupor, trusted subordinate's sudden pain, carbuncle scrofula, laryngopharynx swelling and pain, arthralgia pain numbness; Pemisetum flaccidum Griseb., sweet in the mouth, little hardship, property is flat, clearing away heat-damp and promoting diuresis; Herba Plantaginis, sweet in the mouth, light, cold nature, clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal makes eye bright, and eliminates the phlegm; Anise, warm in nature, sweet in the mouth, suffering, the cold expelling appetizing of regulating the flow of vital energy.Raw material of Chinese medicine reasonable compatibility of the present invention complements each other, and fundamentally treats coronary heart disease, and therapeutic effect is good.
The specific embodiment
Embodiment 1
The Chinese medicine of treatment coronary heart disease is made by the crude drug of following parts by weight: 2 parts of Ramulus Persicae, 2 parts of Herba Potentillae Discoloris, 0.5 part in Moschus, 3 parts of Pemisetum flaccidum Griseb., 2.3 parts of Herba Plantaginiss and anistree 0.5 part.
Embodiment 2
The Chinese medicine of treatment coronary heart disease is made by the crude drug of following parts by weight: 1 part of Ramulus Persicae, 1 part of Herba Potentillae Discoloris, 0.5 part in Moschus, 2 parts of Pemisetum flaccidum Griseb., 1 part of Herba Plantaginis and anistree 0.5 part.
Embodiment 3
The Chinese medicine of treatment coronary heart disease is made by the crude drug of following parts by weight: 3 parts of Ramulus Persicae, 3 parts of Herba Potentillae Discoloris, 1 part in Moschus, 5 parts of Pemisetum flaccidum Griseb., 3 parts of Herba Plantaginiss and anistree 1 part.
During the medication preparation of embodiment 1-3 each raw material is mixed, be ground into fine powder, directly take, four times a day, a 2-3 gram is used warm water delivery service.
Model case
Case 1: Zhang, the man, 76 years old, people from village of Yiyang County Liu Quan township unit, that health in 1989 occurs is uncomfortable in chest, chest pain, the symptom of breathing hard, chest pain shows as compressing, stuffy or austerity, burn feeling is arranged, and increased heart rate, hypertension, perspiration are diagnosed as angina pectoris coronary heart disease, treatment is not cured through many places, outbreak causes very big misery to patient repeatedly, and back 1992 begin to treat with the medicine of the embodiment of the invention 1, take a turn for the better when taking 3 months, the number of times that symptom occurs significantly reduces, after continuing to take 3 months, and transference cure, check to recover normal, after recurrence.
Case 2: Xiao, man, 44 years old, the Sanmenxia City people cardiopalmus, out of breath, irritated, angina pectoris symptom occurred, and increased with heating, tachycardia, leukocyte in 1991 when movable, heart failure occurs when serious, be diagnosed as myocardial infarction type coronary heart disease, the many places treatment is not thoroughly cured, adopted the medicine of embodiment 3 to treat in 1993 upon somebody's introduction, take a turn for the better when taking 4 months, the morbidity number of times significantly reduces, after continued to take 4 months, transference cure check to recover normal, after recurrence.
Case 3: Lee, man, 45 years old, people from area just outside a city gate, Shengchi County suffers from coronary heart disease for many years, and discovery was arranged when cardiac hypertrophy increase, heart failure, paroxysmal tachycardia occurring in 1992, be diagnosed as ischemic coronary heart disease, treated with the medicine of embodiment 2 in 1993, and took a turn for the better when taking 3 months, the number of times that symptom occurs significantly reduces, after continuing to take 3 months, transference cure check to recover normal, after recurrence.
Drug therapy patients with coronary heart disease 160 examples of the present invention are cured 130 examples, 20 examples that take a turn for the better, and 10 examples that do not heal, cure rate reaches 81%.
The coronary heart disease efficacy evaluation:
Cure: continuous three days, it is normal that heart rate recovers, transference cure.
Take a turn for the better: sx.
Do not heal: heart rate, symptom no change.
Claims (2)
1. Chinese medicine for the treatment of coronary heart disease, it is characterized in that: the crude drug by following parts by weight is made:
Ramulus Persicae 1-3 part, Herba Potentillae Discoloris 1-3 part, Moschus 0.5-1 part, Pemisetum flaccidum Griseb. 2-5 part, Herba Plantaginis 1-3 part and anistree 0.5-1 part.
2. the Chinese medicine of treatment coronary heart disease as claimed in claim 1 is characterized in that: the crude drug by following parts by weight is made: 2 parts of Ramulus Persicae, 2 parts of Herba Potentillae Discoloris, 0.5 part in Moschus, 3 parts of Pemisetum flaccidum Griseb., 2.3 parts of Herba Plantaginiss and anistree 0.5 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100482513A CN102119971B (en) | 2011-03-01 | 2011-03-01 | Traditional Chinese medicine for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100482513A CN102119971B (en) | 2011-03-01 | 2011-03-01 | Traditional Chinese medicine for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102119971A true CN102119971A (en) | 2011-07-13 |
| CN102119971B CN102119971B (en) | 2012-05-23 |
Family
ID=44248699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100482513A Expired - Fee Related CN102119971B (en) | 2011-03-01 | 2011-03-01 | Traditional Chinese medicine for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102119971B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109602811A (en) * | 2018-12-27 | 2019-04-12 | 南宁多灵生物科技有限公司 | A kind of drug for treating coronary heart disease |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637556A (en) * | 2009-09-01 | 2010-02-03 | 李增太 | Pharmaceutical composition for treating heart disease and preparation method thereof |
| CN101912482A (en) * | 2010-08-24 | 2010-12-15 | 王延玲 | Traditional Chinese medical powder for treating congenital heart diseases |
-
2011
- 2011-03-01 CN CN2011100482513A patent/CN102119971B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637556A (en) * | 2009-09-01 | 2010-02-03 | 李增太 | Pharmaceutical composition for treating heart disease and preparation method thereof |
| CN101912482A (en) * | 2010-08-24 | 2010-12-15 | 王延玲 | Traditional Chinese medical powder for treating congenital heart diseases |
Non-Patent Citations (2)
| Title |
|---|
| 《实用中医内科杂志》 20060831 钱卫东 辨证治疗冠心病心绞痛临床浅识 380 1-2 第20卷, 第4期 * |
| 《实用中医内科杂志》 20060831 钱卫东 辨证治疗冠心病心绞痛临床浅识 380 1-2 第20卷, 第4期 2 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109602811A (en) * | 2018-12-27 | 2019-04-12 | 南宁多灵生物科技有限公司 | A kind of drug for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102119971B (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN104013919A (en) | Traditional Chinese medicine for treating angina pectoris | |
| CN101843815B (en) | Medicated wine for traumatic injury | |
| CN101199723B (en) | Chinese medicine compound for oral administration for treating lumbar hyperosteogeny | |
| CN104042713B (en) | A kind of Chinese medicine composition for the treatment of bronchial asthma | |
| CN102119971B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN102091169B (en) | Traditional Chinese medicine capsule capable of tonifying liver and kidney, promoting blood circulation by removing blood stasis, dispelling wind, cold and dampness | |
| CN104825956A (en) | Medicine for preventing and treating stroke and recovering muscles, bones and joints | |
| CN102552715B (en) | Chinese medicinal composition, medicine containing Chinese medicinal composition and preparation method of medicine | |
| CN104873685A (en) | Medicine for treating coronary heart disease | |
| CN101274045B (en) | Exterior-applied medicament for treating psoriasis | |
| CN102028876B (en) | Liquid Chinese medicine for treating hyperosteogeny | |
| CN101112562B (en) | Chinese traditional medicine composition for treating hyperosteogeny | |
| CN101112602B (en) | Medicine for treating pharyngitis and method for preparing the same | |
| CN101780194A (en) | Medicament for treating bedsore in clinical care | |
| CN101195002A (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
| CN100348176C (en) | Cervical spondylosis treating Chinese medicine | |
| CN102886037A (en) | Traditional Chinese medicine for treating senile knee joint degeneration and preparation method of traditional Chinese medicine | |
| CN102441088B (en) | Traditional Chinese medicinal liquor used for treating lumbar muscle fiber inflammation | |
| CN102698012A (en) | Externally applied traditional Chinese medicine for treating oral lichen planus | |
| CN103656501B (en) | The medicine pill for the treatment of spontaneous angina pectoris | |
| CN102940848A (en) | Traditional Chinese medicine medicinal liquor for treatment of coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20160301 |